Recombinant Fibroblast Growth Factor-4 (FGF4) and FGF2 induce extracellular signal-regulated kinase-1/2 activation and DNA synthesis in murine aortic endothelial (MAE) cells. These cells co-express the IIIc/Ig-3 loops and the novel glycosaminoglycan-modi®ed IIIc/Ig-2 loops isoforms of FGF receptor-2 (FGFR2). The anity of FGF4/FGFR2 interaction is 20 ± 30 times lower than that of FGF2 and is enhanced by heparin. Overexpression of FGF2 or FGF4 cDNA in MAE cells results in a transformed phenotype and increased proliferative capacity, more evident for FGF2 than FGF4 transfectants. Both transfectants induce angiogenesis when applied on the top of the chick embryo chorioallantoic membrane. However, in contrast with FGF2-transfected cells, FGF4 transfectants show a limited capacity to growth under anchorage-independent conditions and lack the ability to invade 3D ®brin gel and to undergo morphogenesis in vitro. Also, they fail to induce hemangiomas when injected into the allantoic sac of the chick embryo. In conclusion, although exogenous FGF2 and FGF4 exert a similar response in MAE cells, signi®cant dierences are observed in the biological behavior of FGF4 versus FGF2 transfectants, indicating that the expression of the various members of the FGF family can dierently aect the behavior of endothelial cells and, possibly, of other cell types, including tumor cells.
Introduction
The hst oncogene encodes for Fibroblast Growth Factor-4 (FGF4), a member of the FGF family that transforms 3T3 cells with high eciency (Delli Bovi et al., 1987; Moscatelli and Quarto, 1989) . Hst activation results in the overexpression of the growth factor that is eciently secreted and binds to cell surface tyrosine kinase FGF receptors (FGFRs), thus creating an autocrine loop of stimulation (Moscatelli and Quarto, 1989) . Also, FGF4 stimulates endothelial cell proliferation, migration, and protease production in vitro and neovascularization in vivo (Delli Bovi et al., 1988; Yoshida et al., 1994) . FGF2 shares with FGF4 a potent angiogenic activity . The single-copy human fgf-2 gene encodes multiple FGF2 isoforms with molecular weight (MW) ranging from 18 000 ± 24 000 (Florkiewicz and Sommer, 1989) . At variance with FGF4, FGF2 isoforms lack a leader sequence for secretion and have dierent intracellular fates (Renko et al., 1990) . Nevertheless, FGF2 isoform(s) can be secreted in limited amounts by an alternative secretion pathway (Mignatti et al., 1992) and accumulate in the extracellular matrix, from where they are released by degrading enzymes (Ribatti et al., 1999a and references therein) . Overexpression of the dierent FGF2 isoforms may have dierent biological consequences in transfected cells, suggesting that they may play dierent intracellular/extracellular functions (Couderc et al., 1991; Bikfalvi et al., 1995; Escat et al., 2000; Gaubert et al., 2001) . However, both M r 18 000 and M r 24 000 FGF2 isoforms show angiogenic activity in vitro and in vivo (Gualandris et al., 1994) .
A dual receptor model has been proposed for FGFs in which interaction with low anity heparan sulfate (HS) proteoglycans (HSPGs) is required for the high anity interaction with FGFRs (Klagsbrun and Baird, 1991) . HSPGs may induce FGF oligomerization required for receptor dimerization, autophosphorylation and activation of intracellular signaling (SpivakKroizman et al., 1994) . Four FGFR genes have been cloned (FGFR1/¯g: Lee et al., 1989; FGFR2/bek: Dionne et al., 1990; FGFR3: Keegan et al., 1991; and FGFR4: Partanen et al., 1991) . They are characterized by three extracellular immunoglobulin (Ig)-like domains, an acidic box located between the ®rst and second Ig-like loop, a transmembrane domain, and a splitted intracellular catalytic tyrosine-kinase domain. Several alternative spliced RNA variants that dier in the number of Ig-like loops and/or in the absence of the intracellular domain were also described (Johnson and Williams, 1993) . The growth factor binding site of FGFR includes the second half of the third Ig-like loop (Plotnikov et al., 2000) ; three variants of this region, encoded by dierent exons, have been described (Johnson and Williams, 1993; Chellaiah et al., 1994) . IIIc isoforms show a broader spectrum of ligands when compared to IIIb variants (Ornitz et al., 1996) . In particular, FGF2 and FGF4 bind to murine FGFR2/ IIIc/Ig-3 with similar anity in CHO transfected cells (Mansukhani et al., 1992) .
FGFs may exert their eects on endothelial cells via a paracrine mode consequent to their release from producing cells and/or by mobilization from the extracellular matrix. FGF2 may also play an autocrine role in endothelial cells (Gualandris et al., 1996 , and references therein). Accordingly, FGF2 has been implicated in the pathogenesis of lesions of endothelial cell origin, including hemangiomas (Takahashi et al., 1994 ) and Kaposi's sarcoma (KS) (Ensoli et al., 1994a, b) . Interestingly, recent observations have also shown that the FGF4 gene is ampli®ed and expressed in HHV8-positive KS biopsies (Kiuru-Kuhlefelt et al., 2000) . These data suggest that FGFs produced by cells of the endothelial lineage, including KS-derived spindle cells, may play important autocrine and paracrine roles in angiogenesis and in the pathogenesis of vascular lesions.
To assess the biological consequences of endothelial cell activation by endogenous FGFs, we originated an FGF2-overexpressing mouse aortic endothelial cell line (pZipFGF2 MAE cells: Gualandris et al., 1996) . FGF2 transfectants show an invasive and morphogenic behavior in vitro. In vivo, they are angiogenic, cause the formation of opportunistic vascular tumors in nude mice, and induce hemangiomas when injected in the allantoic sac of the chick embryo (Gualandris et al., 1996; Ribatti et al., 1999b) . This latter eect appears to be due to an as yet unidenti®ed heparin-binding FGF2-inducible protein released by pZipFGF2 MAE cells and able to confer morphogenic and invasive capacity when added to parental MAE cells (Ribatti et al., 1999b) .
In the present work, we decided to investigate the interaction of exogenous FGF4 with MAE cells and to assess the impact of FGF4 overexpression on the biological behavior of MAE transfectants in vitro and in vivo when compared to FGF2 transfectants. The results show that exogenous FGF2 and FGF4 exert a similar response in MAE cells. In contrast, signi®cant qualitative dierences are observed in the biological behavior of these cells following the endogenous expression of the two growth factors. This may re¯ect dierences in the intracellular/extracellular fate of FGF4 in respect to FGF2 isoforms.
Results

Interaction of exogenous FGF4 with MAE cells
MAE cells express FGFR2 . Accordingly, recombinant FGF2 and FGF4 stimulate DNA synthesis when administered to these cells. The mitogenic activity of FGF4 appears to be approximately 10 times less potent than that of FGF2 and is enhanced by heparin (Figure 1a) . Also, both growth factors trigger ERK 1/2 phosphorylation at a saturating concentration equal to 10 ng/ml (Figure 1a , insert). In agreement with its mitogenic capacity, FGF4 was 20 ± 30 times less potent than FGF2 in competing for the binding of 125 I-FGF2 to FGFRs in MAE cells ( Figure  1b) . Unmodi®ed heparin, but not 2-O-desulfated heparin, was able to increase signi®cantly the anity of FGF4 for the receptor (Figure 1b) , suggesting that cell surface HS may play a role in FGF4/FGFR2 interaction in these cells. No signi®cant eect was instead exerted by 100 nM unmodi®ed heparin or 2-Odesulfated heparin on FGF2/FGFR2 interaction (data not shown).
FGFR2/IIIc/Ig-3 loops isoform binds FGF2 and FGF4 with similar anity (Mansukhani et al., 1992) . In order to identify the FGFR2 isoform(s) expressed by MAE cells, we designed dierent oligonucleotide primers spanning the extracellular domain of the murine receptor (Figure 2a ). When MAE cells were compared by RT ± PCR analysis to NIH3T3 cells transfected with the FGFR2/IIIc/Ig-3 loops isoform (see Materials and methods), an identical pattern of ampli®cation was observed using primers spanning the second and third Ig-like loops. In contrast, one extra band of approximately 100 bp was detected in MAE cells using primers that span the ®rst Ig-like loop (Figure 2b ). On this basis, a more expanded fragment spanning the region anticipated to contain the signal peptide sequence, the ®rst Ig-like loop, and the acidic box was ampli®ed and cloned. Nucleotide sequence (not shown) indicates that this fragment actually encodes for the N-terminus of the FGFR2/IIIc/Ig-2 loops variant (Twigg et al., 1998) and contains the HSmodi®ed Ser-Ser-Gly motif in its acidic domain (Sakaguchi et al., 1999) (Figure 2c ). Cross-linking of MAE cell surface receptors with 125 I-FGF2, followed by SDS ± PAGE and 1 week exposure of the gel to a FLA2000 PhosphoImager screen (Fuji), showed the presence of a faint broad band with M r 140 000 ± 210 000 (data not shown), as already observed for NIH3T3 cells overexpressing the HS-modi®ed FGFR2/ IIIc/Ig-2 loops isoform (Sakaguchi et al., 1999) , suggesting that both the IIIc/Ig-3 loops and the IIIc/ Ig-2 loops isoforms of FGFR2 are exposed on the cell surface. However, the limited number of FGFRs and the coexpression of two isoforms made unfeasible the assessment of the contribution of each individual FGFR2 isoform to FGF2 and FGF4 binding.
FGF4 overexpression in MAE cells: effects in vitro
FGF2 overexpression confers a transformed, angiogenic phenotype to transfected MAE cells (pZipFGF2-MAE cells) associated with an invasive and morphogenic behavior in vitro (Gualandris et al., 1996) . To assess the impact of FGF4 overexpression in MAE cells, human FGF4 cDNA was cloned in the same retroviral expression vector utilized to generate the pZipFGF2-MAE cells, and the construct was transfected in the parental cell line. After G418 FGF4 overexpression in endothelial cells P Dell'Era et al selection, conditioned media from dierent clones were loaded on heparin-Sepharose columns and 2.0 M NaC1 eluates were assessed for FGF4 protein expression. Among them, one clone, named pZipFGF4-MAE cells, was used for further experiments. As shown in Figure  3a , FGF4 is released by pZipFGF4-MAE cells at approximately 3 ng/24 h/10 6 cells and accumulates in the conditioned medium. In contrast, both the M r 18 000 and the HMW FGF2 isoforms accumulates intracellularly in pZipFGF2-MAE cells (Figure 3a ). These cells actually release limited amounts of FGF2 in their conditioned medium, corresponding approximately to 30 pg/24 h/10 6 cells (Ribatti et al., 1999b) . In agreement with previous observations (Gualandris et al., 1996) , pZipFGF2-MAE cells showed a transformed phenotype ( Figure 4 ) and a marked increase in cell proliferation and saturation density when compared to parental cells ( Figure 3b ). Moreover, they underwent morphogenesis when seeded on Matrigel and showed an invasive behavior and sprouting activity in 3D ®brin gel (Figure 4 ). FGF4 transfectants acquired a transformed morphology and showed a 2.5-fold increase of their proliferation rate and saturation density. However, they failed to invade ®brin gel and to form tube-like structures on Matrigel (Figures 3b and 4) . Also, pZipFGF4-MAE cells showed a limited capacity to grow under anchorageindependent conditions when compared to FGF2 transfectants (104+17, 15+3, and 2+1 colonies/®eld for pZipFGF2, pZipFGF4, and parental cells, respectively). Moreover, the size of pZipFGF4-MAE colonies was signi®cantly smaller than that of pZipFGF2-MAE colonies ( Figure 4 ).
FGF4 overexpression in MAE cells: effects in vivo
pZipFGF2-MAE cells induce angiogenesis when implanted on the top of the chorioallantoic membrane (CAM) and cause hemangioma formation when injected into the allantoic sac of the chick embryo (Table 1 and Ribatti et al., 1999b) . The former but not the latter activity is inhibited by neutralizing anti-FGF2 antibody (Ribatti et al., 1999b) . When tested under the same experimental conditions, pZipFGF4-MAE cells induce angiogenesis on the CAM but are unable to cause hemangiomas when injected into the allantoic sac (Table 1 ).
An as yet unidenti®ed heparin-binding FGF2-inducible protein appears to be responsible for the hemangioma-inducing capacity of FGF2 transfectants (Ribatti et al., 1999b) . This molecule stimulates parental MAE cells to originate endothelial sprouts in 3D ®brin gel (Ribatti et al., 1999b) . In agreement with the in vivo observations, only the pZipFGF2-MAE cellconditioned medium stimulates endothelial sprouting whereas the conditioned media of both transfectants exerted a signi®cant mitogenic activity on MAE cells ( Figure 5) . Accordingly, the conditioned medium of FGF2 transfectants stimulates the sprouting of endothelial 1G11 cells (Dong et al., 1997) whereas the conditioned medium of pZipFGF4-MAE cells is ineective (Figure 5 ), despite the fact that both I-FGF2 (3 ng/ml) in the presence of increasing concentrations of unlabeled FGF2 (~) or FGF4 added alone (*) or with 100 nM unmodi®ed heparin (UFH, &) or 100 nM 2-O-desulfated heparin (2-O-des.H, *). Then, radioactivity bound to high anity FGFRs was measured FGF2 and FGF4 are able to exert a signi®cant mitogenic response also in this endothelial cell type (data not shown). Similar results were obtained when conditioned media and recombinant proteins were tested in the fetal bovine aortic endothelial GM7373 cell line (Grinspan et al., 1983 ) (data not shown).
Discussion
In the present paper we investigated the eects of exogenous and endogenous FGF4 on MAE cell behavior in vitro and in vivo. Northern blot analysis demonstrated that MAE cells express FGFR2 . The IIIc/Ig-3 loops isoform of this receptor had been shown to bind FGF2 and FGF4 with similar anity (Mansukhani et al., 1992) . Our data demonstrate that human recombinant FGF2 and FGF4 elicit similar biological responses in MAE cells by triggering receptor downstream signaling, exempli®ed by ERK 1/2 phosphorylation (Besser et al., 1995) , and stimulating DNA synthesis, although the potency of the mitogenic activity of FGF4 appears to be lower I-FGF2 have shown that the anity of FGF4 for FGFRs in MAE cells is lower than that of FGF2. Heparin causes a signi®cant increase of the anity of FGF4 for FGFR interaction. The eect appears to be speci®c since 2-Odesulfated heparin, that does not interact with FGF4 (Guimond et al., 1993) , is ineective and unmodi®ed heparin does not aect the receptor-binding capacity of FGF2. Recent data have shown that the acidic box of the FGFR2/IIIc/Ig-2 loops isoform can be covalently modi®ed by HS chains in its Ser-Ser-Gly-motif (Sakaguchi et al., 1999) and that both the receptor core protein and the glycosaminoglycan modi®cation are required for binding. By RT ± PCR analysis of the cellular transcripts, we demonstrate that MAE cells express both the FGFR2/IIIc/Ig-3 loops and the FGFR2/IIIc/Ig-2 loops isoforms and that the latter one contains the Ser-Ser-Gly-motif. These observations, together with the data obtained from crosslinking experiments with radiolabeled FGF2, strongly suggest that both isoforms are expressed on MAE cell surface and that the FGFR2/IIIc/Ig-2 loops isoform is indeed HS modi®ed. To our knowledge this is the ®rst demonstration of the expression of dierent FGFR2 isoforms in endothelial cells. Further experiments on appropriate FGFR2 transfectants will be required to assess the contribution of each isoform and of HS modi®cation to FGF2 and FGF4 binding and biological responses.
Taken together, our data indicate that exogenous FGF2 and FGF4 act on endothelial cells in vitro in a similar manner even though signi®cant dierences may exist in their anity for FGFRs and in their susceptibility to the extracellular glycosaminoglycan milieu. This appears to be in keeping with recent observations concerning the role of cell surface HSPGs in modulating the speci®city of FGFR2/IIIc (Uematsu et al., 2000) .
FGF2 overexpression deeply aects the biological behavior of endothelial cells (present paper and Gualandris et al., 1996) . Indeed, pZipFGF2-MAE cells show a transformed morphology, an increased saturation density, and the capacity to grow under anchorage-independent conditions. Also, they show an invasive behavior and sprouting activity in threedimensional ®brin gels, and the ability to form a complex network of branching cord-like structures connecting foci of in®ltrating cells when seeded on Matrigel. Furthermore, they are able to induce an angiogenic response in the CAM and cause the formation of hemangiomas when injected into the allantoic sac of the chick embryo (present paper and Ribatti et al., 1999b) . To investigate the impact of the expression of endogenous FGF4 on endothelial cell behavior, MAE cells were transfected with a human FGF4 cDNA. pZipFGF4-MAE cells were characterized by an elevated production and release of FGF4 protein. FGF4-overexpression induces a transformed phenotype in NIH3T3 cells as the consequence of an extracellular autocrine loop of stimulation (Talarico and Basilico, 1991) . Accordingly, pZipFGF4-MAE cells are characterized by a transformed morphology, an increased saturation density, but a limited capacity to grow under anchorage-independent conditions. As observed for NIH3T3 cell transfectants (Moscatelli and Quarto, 1989) , suramin, a polysulfonate compound able to prevent FGF/FGFR interaction (Sato and Nevertheless, signi®cant dierences exist between FGF2-and FGF4-transfected MAE cells both in vitro and in vivo. pZipFGF4-MAE cells showed a proliferation rate lower than that of FGF2 transfectants, were unable to sprout in 3D ®brin gel, and did not undergo morphogenesis on Matrigel. Also, they lack the ability to induce hemangiomas in the CAM. Furthermore, their conditioned medium does not show any endothelial sprouting-inducing activity in vitro. All these biological features were instead present in FGF2 transfectants and appear to be the consequence of the release of an as yet unidenti®ed heparin-binding factor that can be isolated from pZipFGF2-MAE conditioned medium (Ribatti et al., 1999b) . Interestingly, experimental evidences suggest that the production of this protein may be due to an intracellular mode of action of the overexpressed, endogenous FGF2 (Ribatti et al., 1999b) .
FGF2 cDNA overexpression leads to the production of both low and HMW FGF2 isoforms that are poorly released by transfected cells. Experimental evidences point to dierent functions of FGF2 isoforms (Couderc et al., 1991; Bikfalvi et al., 1995; Escat et al., 2000; Gaubert et al., 2001) , possibly related to dierences in their subcellular localization and release. Indeed, HMW FGF2 isoforms are mostly recovered in the nucleus whereas M r 18 000 FGF2 is mostly cytosolic (Renko et al., 1990) . In adult bovine aortic endothelial cells and NIH3T3 cells, the constitutive overexpression of HMW FGF2 isoforms leads to cell immortalization whereas M r 18 000 FGF2 overexpression induces a transformed phenotype (Couderc et al., 1991; Quarto et al., 1991) . In contrast, FGF4 is eciently released by producing cells and does not appear to play an intracellular role (Talarico and Basilico, 1991) . On this basis, it is tempting to hypothesize that the biological dierences observed between pZipFGF4-MAE and pZipFGF2-MAE cells are due to intracrine function(s) exerted by the HMW FGF2 isoforms in the latter transfectants. Further experiments aimed to investigate the pattern of gene expression in pZipFGF4-MAE cells, pZipFGF2-MAE cells, and in MAE cells transfected with the individual FGF2 isoforms are in progress in our laboratory to assess this hypothesis.
KS-derived spindle cells of endothelial origin express both FGF2 and FGF4 at high levels (Ensoli et al., 1994a,b; Kiuru-Kuhlefelt et al., 2000) . Our data shed a new light on the biological signi®cance of the overexpression of the two angiogenic factors in KS. Also, FGF4/hst gene ampli®cation has been observed in human tumors of dierent origin (Theillet et al., 1989; Shimon et al., 1998; Oliver, 1999) . In this context, our data indicate that FGF2 and FGF4 expression may aect angiogenesis by a paracrine mechanism of action and exert dierent autocrine eects on the producing cells. In conclusion, our data demonstrate that exogenous FGF2 and FGF4 exert a similar response in MAE cells. In contrast, signi®cant dierences are observed in the biological behavior of these cells following the endogenous expression of the growth factors. Overexpression of dierent members of the FGF family in endothelial cells may represent a novel approach to investigate their impact on endothelial cell behavior in vitro and in vivo.
Materials and methods
Cell cultures and transfection
Balb/c mouse aortic endothelial 22106 cells (MAE cells; Bastaki et al., 1997) and pZipFGF2-MAE cells (Gualandris et al., 1996) were grown in DMEM plus 10% fetal calf serum (FCS) in the absence or in the presence of 500 mg/ml of G418 sulfate (Calbiochem), respectively.
The expression vector pZipFGF4 was obtained by inserting the human FGF4 cDNA (Delli Bovi et al., 1987) under the control of the Mo-MuLV LTR elements into pZipNeoSV(X), the expression vector used to generate pZipFGF2-MAE cells (Gualandris et al., 1996) . MAE cells were transfected with a calcium phosphate precipitate containing 20 mg of plasmid DNA [either pZipFGF4 or pZipNeoSV(X)]. After G418 selection, conditioned media from dierent clones were loaded on heparin-Sepharose columns and 2.0 M NaC1 eluates were screened for FGF4 presence by Western blot analysis and for the capacity to induce [ NIH3T3 cells were transfected with the expression vector pZipNeoSV(X) harboring the murine FGFR2/IIIc/Ig-3 isoform cDNA (Mansukhani et al., 1992) . Stable transfectants were characterized for [ 125 I]FGF-2 binding as described below.
1G11 cells (Dong et al., 1997) were grown on gelatincoated dishes in DMEM supplemented with 1 mM glutamine, 1% non-essential amino acids, 1 mM sodium pyruvate and 20% FCS.
Immunoblot analysis
Subcon¯uent cultures were washed with serum-free medium and incubated for 48 h with fresh medium. At the end of the incubation, conditioned medium was collected. Cell monolayers were washed twice with PBS and once with 2 M NaC1 in PBS. The 2 M NaC1 wash was collected and diluted with PBS to 0.5 M NaC1. Conditioned medium, containing the free growth factor(s), and diluted 2 M NaC1 wash, containing the growth factor(s) released from the extracellular matrix, were loaded onto 100 ml heparin-Sepharose columns. The resin was transferred to an Eppendorf tube, washed twice with PBS and added with SDS ± PAGE reducing sample buer. In the meantime, cell monolayers were scraped from the dish and sonicated in SDS ± PAGE reducing sample buer with three bursts of 10 s each at 50 W. Cells extracts and resin beads were boiled, proteins were run on SDS-15% PAGE, transferred to nitrocellulose membranes, and probed with anti-FGF2 or anti-FGF4 polyclonal antibodies (provided by DB Rifkin and C Basilico, New York University Medical Center, NY, USA, respectively).
To evaluate extracellular signal-regulated kinase-1/2 (ERK 1/2 ) phosphorylation, MAE cells were treated for 20 min with 10 ng/ml of FGF2 or FGF4. Western blot analysis of the cell extracts was performed by using antiphospho-ERK 1/2 antibody (Santa Cruz Biotechnology). Immunocomplexes were visualized by chemiluminescence utilizing the Supersignal 1 West Pico chemiluminescent substrate (Pierce) according to manufacturer's instructions.
RT ± PCR analysis and characterization of FGFR2 isoforms RNA was extracted from exponentially growing cells as described (Chomczynski and Sacchi, 1987) . Two mg of total RNA were retrotranscribed with Ready-To-Go TM You-Prime First Strand Beads (Amersham Pharmacia Biotech), using a 18 mer oligo-dT primer. One tenth of the reaction was subjected to 35 cycles of polymerase chain reaction (PCR) using dierent oligonucleotide primers spanning the extracellular domain of the murine receptor (Figure 2a) . The fragment obtained with the primers indicated by the black arrows in Figure 2a was cloned in pSTBlue-1 using a Perfectly Blunt TM cloning kit (Novagen), and automatically sequenced with a 373 Applied Biosystem Sequence Analyzer.
Cell proliferation assay
Human recombinant FGF2 (Isacchi et al., 1991) and FGF4 (provided by C. Basilico) and serum-free conditioned media from parental MAE, pZipFGF2-MAE, and pZipFGF4-MAE cells were tested for the ability to stimulate [ H-thymidine (1 mCi/ ml) for 6 h. Then, the amount of radioactivity incorporated into the trichloroacetic acid-precipitable material was measured. I (37 GBq/ml; NEN Life Science) using Iodogen (Pierce) (Moscatelli, 1987) . Cells were seeded in 24-well dishes at the density of 80 000 per cm 2 . After 24 h, cells were washed with ice-cold PBS and incubated for 2 h at 48C in serum-free medium containing 0.15% gelatin, 20 mM HEPES buer, pH 7.5, added with 3 ng/ml (Moscatelli, 1987) . When indicated, 100 nM unmodi®ed or 2-O-desulfated heparin (Coltrini et al., 1994) were added to the binding medium.
Soft agar colony formation assay
Cells were plated at 20 000 cells/35 mm dish in 0.25% agar as described (Quarto et al., 1991) . For each cell types, colonies in 10 microscopic ®elds were counted at a 40-fold magni®cation 15 days after seeding.
Matrigel assay
Twenty-four well-plates were coated with 250 ml/well of 10 mg/ml Matrigel (Becton Dickinson, Milan, Italy) at 48C. After gelling at 378C, cells were seeded onto Matrigel layers at 150 000 cells/well. Cultures were observed after 48 h for the formation of`capillary-like' structures (Grant et al., 1989) .
3D-fibrin gel assay
Fibrinogen (2.5 mg/ml) was dissolved in calcium-free medium. Then, cell aggregates (Gualandris et al., 1996) were resuspended in the ®brinogen solution and clotting was started by addition of thrombin (250 mU/ml). The mixture was transferred into 24 well-plates and allowed to gel at 378C. Trasylol (200 KIU/ml) was added to the gel and to the culture medium to prevent the dissolution of the substrate. Cultures were maintained for 2 ± 3 days in DMEM and observed for the generation of endothelial sprouts (Gualandris et al., 1996) . When indicated, ®brinogen and culture medium were added with a 1 : 10 dilution (v : v) of pZipFGF2 or pZipFGF4 MAE cell conditioned medium as described (Ribatti et al., 1999b) .
Cell injection into the chick embryo allantoic sac
Fertilized chicken eggs were incubated under routine conditions, and a square window was opened in the egg shell at the third day of incubation after removal of 2 ± 3 ml of albumen to detach the shell from the developing CAM. The window was sealed with a glass and the eggs returned to the incubator. Then, 200 ml of a cell suspension containing 6610 6 cells per ml of PBS were injected twice into the allantoic sac at day 8 and day 9. Eggs were examined daily for the formation of macroscopic hemangiomas until day 12 (Ribatti et al., 1999b) .
Cell delivery onto the CAM and quantification of the angiogenic response
Gelatin sponges (Gelfoam, Upjohn Company) were cut to the size of 1 mm 3 and placed on top of the CAM at day 8 (Ribatti et al., 1997) . Then sponges were absorbed with 3 ml of cell suspension (18 000 cells per sponge). Sponges containing vehicle alone were used as negative controls. CAMs were examined daily, photographed in ovo and processed for light microscopy at day 12. The angiogenic response was assessed histologically by a planimetric method of`point counting' (Ribatti et al., 1999b) .
